Cataract & Refractive 360: Focus on Perioperative Considerations for Successful Patient Outcomes - Volume 5, Number 3
This activity is supported by educational grants from Alcon Vision, LLC; Bausch + Lomb; Carl Zeiss Meditec, Inc.; J&J Vision; and STAAR Surgical.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by educational grants from Alcon Vision, LLC; Bausch + Lomb; Carl Zeiss Meditec, Inc.; J&J Vision; and STAAR Surgical.
Activity Description
Evolving technologies and refined techniques for cataract and refractive surgery continue to develop, increasing the number of options for improving visual acuity and enhancing patient quality of life. Successful cataract and refractive surgery rely on an interprofessional team, each playing a role in the multifactorial process from preoperative assessment to postoperative care. Of the many vision correction techniques available, selection can be challenging and must take into consideration patient preferences, characteristics, and expectations. In this CE monograph, experts in the field discuss the need for presurgical preparation of the cataract and refractive surgery patient, including the importance of lid and ocular surface disease management. They also evaluate new and emerging options for the evaluation and management of patients with presbyopia; describe advanced tools and techniques for the refractive cataract surgeon; assess the latest evidence regarding the management of inflammation, pain, infection, and miosis; and review interprofessional approaches to care that can improve efficiency and overall outcomes for patients undergoing cataract refractive procedures.
Target Audience
The intended audience for this activity is ophthalmologists, optometrists, and other healthcare professionals involved in the management of patients undergoing cataract and/or refractive surgery.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Recognize the need for presurgical preparation of the cataract and refractive surgery patient, including lid and ocular surface disease management.
- Describe interprofessional approaches to care that can improve efficiency and overall outcomes for patients undergoing cataract refractive procedures.
- Review new and emerging options for the evaluation and management of patients with presbyopia.
- Describe advanced tools and techniques for the refractive cataract surgeon.
- Examine the latest evidence regarding the management of inflammation, pain, infection, and miosis.
Activity Chair
Elizabeth Yeu, MD
Cornea, Cataract, External Disease and Refractive Surgery
Virginia Eye Consultants/EyeCare Partners
Assistant Professor, Eastern Virginia Medical School
President, American Society of Cataract and Refractive Surgery (ASCRS)
Norfolk, VA
Faculty
Nicole R. Fram, MD
Managing Partner
Advanced Vision Care
Los Angeles, CA
John A. Hovanesian, MD
Harvard Eye Associates
Laguna Hills, CA
Cecelia Koetting, OD, FAAO, DipABO
Clinical Faculty
University of Colorado School of Medicine
Department of Ophthalmology
Denver, CO
George O. Waring IV, MD, FACS
Founder and Medical Director
Waring Vision Institute
Mount Pleasant, SC
Medical Writer
Pranali Pathare Mangat, PhD
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing educat
ion for the healthcare team. This activity will also award credit for optometry (COPE) if the requirements necessary for credit are met.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education designates this enduring activity for a maximum of 1.0 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
COPE Course Number: 90799-PO
COPE Activity Number: 128171
This enduring material is approved for 1 year from the date of original release, March 29, 2024, to March 28, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or CE Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The articles in this monograph were composed by medical writer Pranali Pathare Mangat, PhD, based on the presentations of Drs. Fram, Hovanesian, Koetting, Waring, and Yeu during a live webinar held on December 10, 2023. The monograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Elizabeth Yeu, MD
Consultant: AcuFocus, Adaptilens, Advanced Vision, Aldeyra, Allergan, Aurion, Avellino, Bausch + Lomb, BioTissue, BlephEx, Bruder, BVI, Centricity, CorneaGen, Dompé, Elios, Expert Opinion, Eyenovia, Foresight, Glaukos, Guidepoint, Iveric Bio, J&J Vision, Kala, LayerBio, Lensar, Melt, Merck, New World Medical, Novartis, Ocular Science, OCuSOFT, Samsara, ScienceBased Health, Sight Sciences, STAAR, Surface, Tarsus, Théa, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon
Independent Research Contractor: AcuFocus, Alcon, BioTissue, New World Medical, Ocular Science, Tarsus
Individual Stocks and Stock Options (publicly traded): STAAR, Tarsus
*Individual Stocks and Stock Options (privately held): Aurion
Nicole R. Fram, MD
Advisor: Aurion, CorneaGen, J&J Vision, Ocular Science, Orasis
Consultant: Alcon, Aldeyra, Aurion, CorneaGen, Glaukos, J&J Vision, New World Medical, RxSight, Zeiss
Speaker Contracted by Ineligible Company: Alcon, J&J Vision
Independent Research Contractor: Ocular Therapeutix, Zeiss
John A. Hovanesian, MD
Royalties or Patent Beneficiary: SLACK Books
Advisor: Apellis, Bausch + Lomb, BlephEx, Bruder, BVI, Cord LLC, Dompé, Eyedetec, EyePoint, Glaukos, Glint Pharma, HASA OPTIX, Horizon, HOYA, Novartis, Ocular Therapeutix, Omeros, Orasis, Rayner, Sight Sciences, SightLife, Sun Pharma, Trefoil, Visus, Zeiss
Consultant: AcuFocus, Aerie, Alcon, Allergan, Apellis, Avellino, Azura, BlephEx, Bruder, BVI, Centricity Vision, Cloudbreak Therapeutics, Cord LLC, Dompé, Eyedetec, EyePoint, Glaukos, GSK, Glint Pharma, Gobiquity, HASA OPTIX, Horizon, HOYA, Imprimis, J&J Vision, Kala, Novartis, Ocular Therapeutix, Oculis, Omeros, OnPoint Vision, Orasis, Oyster Point Pharma, Rayner, Research Insights, Sensimed, SightLife, Sun Pharma, Tarsus, TearLab, Théa, touchOPHTHALMOLOGY, Trefoil, Visus, Zeiss
Speaker Contracted by Ineligible Company: AcuFocus, Aerie, Alcon, Allergan, Bausch + Lomb, Cord LLC, EyePoint, Glaukos, Imprimis, Johnson & Johnson Vision, Novartis, Ocular Therapeutix, Omeros, OnPoint Vision, Research Insights, Sight Sciences, Sun Pharma, Zeiss
Individual Stocks and Stock Options (publicly traded): Alcon, Allegro, Allergan, CRISPR, Guardion Health Sciences, J&J Vision, Novartis, Ocular Therapeutix, RxSight, Sight Sciences, Tarsus
*Individual Stocks and Stock Options (privately held): Alicia Surgery Center, Cloudbreak Therapeutix, Cord LLC, CorneaGen, Eyedetec, Gobiquity, Harvard Eye Associates, Orasis, Research InSight, SightLife, TearClear, Versant Ventures, Visionary Ventures Fund 1 and 2
Cecelia Koetting, OD, FAAO, DipABO
Consultant: Allergan, Aldyera, Avallino, Alcon, Azura, Bausch + Lomb, Bruder, Claris Bio, Dompé, Eyevance/Santen, Glaukos, Horizon, Ivantis, Iveric Bio, Kala, LENZ, Myze, Orasis, Ocular Therapeutix, Oyster Point, RVL, Scope, SightSciences, Twenty/Twenty Therapeutics, Tarsus, Théa, Visus
Speaker contracted by an ineligible company: Alcon, Bausch + Lomb, Dompé, Eyevance/Santen, Oyster Point, RVL, SightSciences, Tarsus
Independent Research Contractor: Tarsus, Ocular Therapeutix
George O. Waring IV, MD, FACS
Advisor: ACE Vision, AcuFocus, Alcon, Allergan, Allotex, Avedro, Bausch + Lomb, Dompé, EyePoint, GlassesOff, J&J Vision, Novartis, Omega Ophthalmics, Omeros, Optoquest, Perfect Lens, Science Based Health, Shire, Sight Sciences, SRD Vision
Consultant: ACE Vision, AcuFocus, Alcon, Allergan, Allotex, Avedro, Bausch + Lomb, Dompé, EyePoint, GlassesOff, J&J Vision, Novartis, Omega Ophthalmics, Omeros, Optoquest, Perfect Lens, Science Based Health, Shire, Sight Sciences, SRD Vision
Speaker for Ineligible Company: Oculus, Omeros, Shire
Independent Research Contractor: AbbVie/Allergan, Avedro
Individual Stock & Stock Options (publicly traded): RxSight
*Individual Stock & Stock Options (privately held): AcuFocus, Atia Vision, Omega Ophthalmics, RxSight, Visiometrics
*Will not discuss business lines or products of the company(ies).
Medical Writer reports the following relevant financial relationship(s)
Pranali Pathare Mangat, PhD
No relevant financial relationships to disclose.
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com